Determination of diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone in plasma by solid-phase extraction and high-performance liquid chromatography.
Betteridge
R F
RF
Bath Cancer Research Unit, Royal United Hospital, U.K.
Bosanquet
A G
AG
Hunt
P
P
Gilby
E D
ED
D000970:Antineoplastic Agents / Q000097:blood* / Q000493:pharmacokinetics; D001388:Aziridines / Q000097:blood* / Q000493:pharmacokinetics; D001389:Azirines / Q000097:blood*; D016227:Benzoquinones; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D006801:Humans; D011485:Protein Binding; D013056:Spectrophotometry, Ultraviolet; D014461:Ultracentrifugation
D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D016227:Benzoquinones; C029108:diaziquone